
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
Hajjar, Ali, Ergun, Mehmet A., Alagoz, Oguzhan, Rampurwala, Murtuza, Buyukhatipoglu, HakanVolume:
14
Langue:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0217778
Date:
June, 2019
Fichier:
PDF, 946 KB
english, 2019